Psychiatry & Neurology Doctors in Buda, TX Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Dr. Richard Sawyers, Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 5330 Overpass Rd Ste 100, Buda, TX 78610 Phone: 737-999-6600    Fax: 737-999-6601

Dr. Jonathan Theo, DO Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 5235 Overpass Rd, Buda, TX 78610 Phone: 512-504-0888

Dr. Andrew Alan Collins, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 5235 Overpass Rd, Buda, TX 78610 Phone: 512-324-3540    Fax: 512-324-3541

News Archive

Soligenix reports results from orBec Phase 2 trial on acute GVHD

Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.

Research shows how sign language exposure affects young cochlear implant recipients

In a new, multisite study of deaf children with cochlear implants, UT Dallas researchers have found that children with either no exposure or limited exposure to sign language end up with better auditory, speaking and reading skills later.

Masimo SET pulse oximetry screening effective for early diagnosis of critical CHD in newborns

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published online in the German pediatric journal, Klinische Padiatrie, showed that adding Masimo SET pulse oximetry screening to the physical examination of newborns was an effective method to achieve early diagnosis of critical congenital heart disease (CHD).

Seroconversion marks recovery from COVID-19

Nine months into the COVID-19 pandemic, scientists are still seeking to understand the protective immunity that develops against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the increasing need for serological tests in epidemiology, their clinical value has not been fully established. A new paper published in the Journal of Medical Virology in September 2020 describes the relationship of COVID-19 disease symptoms with the serological status over time.

Read more Medical News

› Verified 7 days ago